Study Finds Truvada May Also Lower Herpes Infection Rate
Researchers have discovered another exciting potential benefit of Truvada, the drug that currently used a pre-exposure prophylaxis (PREP) to prevent HIV. The drug may also lower the rate of infection of genital herpes!
From HIVPlus Magazine:
The ongoing debate about the efficacy of Truvada as pre-exposure prophylaxis (PrEP) to prevent HIV infection just got a new wrinkle: a new study suggests the drug can also lower infection rates of genital herpes, despite opponent concerns that use of PrEP would lead to an increase in STDs including herpes.
The study of 131 heterosexual couples in Kenya and Uganda sought to determine if Truvada was effective in reducing rates of herpes simplex virus type 2 (HSV-2). Couples were considered at high risk of infection because they were in a sero-discordant relationship. The study focused on the transmission rates of HSV-2, which were reduced by 30 percent among those taking Truvada.
Although the results are promising, it is not expected to lead to usage of Truvada as a preventative measure for herpes.
Whether or not Truvada becomes a part of regimen to prevent genital herpes transmission, it's certainly an exciting finding as researchers continue working to find ways to stop the transmission of HIV and other sexually transmitted diseases.
What do you think of the study's findings, Instincters?